Ann: Next Science Investor Presentation May 2019, page-15

I’m not going to argue with you but your analysis is a little simplistic. Healthcare users of products are not SaaS subscribers you’re right, but they do have highly repetitive prescribing behaviours - there’s a few reasons for that that I won’t go into in a lot of detail but it’s more defensible as a revenue stream than say, a consumer product.

Also, the year to date sales figures aren’t a good proxy because the sales force has only just become trained on it, and they have to become comfortable and get some intial feedback to understand how providers are using the product.

Finally, sales are in USD, market cap in AUD.